β-Caryophyllene
In vitro / AnimalMechanism of Action
Research Notes
CB2 receptor partial agonism established. Anti-inflammatory activity documented in multiple animal models. Analgesic effects demonstrated without psychoactive CB1 activation.
β-Caryophyllene has been identified as the first dietary cannabinoid. Multiple in vitro studies confirm potent CB2-mediated anti-inflammatory activity. Animal studies demonstrate efficacy in neuropathic and inflammatory pain models. A 2014 preclinical study showed significant attenuation of LPS-induced neuroinflammation. Human clinical data on β-caryophyllene specifically is still preliminary but consistent with in vivo pharmacology.
Found In 2 Herbs
3D Molecular Structure
β-Caryophyllene
Representative pattern: C₁₀H₁₆O
Related Compounds (Sesquiterpene)
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.

